Drug Information Association Logo

DIA Marketing Pharmaceuticals 2011 Explores How Marketing Is Conducted in a Highly Regulated Environment

Horsham, PA, USA — Jan 26, 2011

DIA will host Marketing Pharmaceuticals 2011: Workshop for Regulatory Professionals and Promotional Review Teams from February 21-23, 2011 in Washington, DC. 

Marketing Pharmaceuticals 2011 provides a better understanding of how the regulatory and legal environment has evolved, guidance on what can be learned from the latest FDA enforcement actions, and breakout sessions designed for each member of your promotional review team to help foster a common understanding of how marketing is conducted in a highly regulated environment. Session topics include:

  • FDA Update: Recent Enforcement Actions
  • Meeting the Federal and State Requirements for Appropriate Marketing Practices
  • Ins and Outs of Social Media
  • DDMAC: Update on Social Media
  • FDAMA 114: Interacting with Payors
  • Levels of Evidence
  • CVM Breakout
  • FDA Regulation of Device Promotion
  • MSLs and the Sales Force
  • Non-Traditional Forms of Product Communication: Promotional
  • Activity or Not – That Is The Question
  • Question and Answer Session with FDA

“This three-day conference will explore what is permissible and what is not from a US regulatory and legal standpoint, says Program Committee Member Minnie Baylor-Henry, JD, Regulatory & Capital Markets Consulting, Deloitte & Touche LLP. “If you are a regulatory affairs professional and traditionally attend this annual meeting, now is the time to bring your promotional review team members together to learn about the latest enforcement actions directly from FDA DDMAC officials, government counsel, and other industry professionals.”






ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.